In addition, we observed statistically significant differences in the editing levels of ATXN3 | chr14:92526779, LOC100130744 | chr5:14716392, METTL2A | chr17:60528133, PEX26 | chr22:18572607, and UGGT1 | chr2:128949284 between BRCA tumours and normal tissues, suggesting that aberrant editing of these ATIRE sites may be associated with BRCA development. Here, ATXN3 is linked to invasive breast carcinoma.